Within this framework, anti-obesity medications (AOMs) emerge as a supportive strategy under pharmacotherapy, which is one of the three main evidence-based approaches to obesity treatment [11, 12]
Our team of experts will guide you through the process, ensuring you receive the best care tailored to your needs
Data were analyzed in three ways: acute administration (injection 1), repeated administration (injections 1, 3, and 8), and post-treatment effects (days 1 and 3 post-treatment)
Trulicity and Januvia are both approved for the treatment of type 2 diabetes mellitus in adults: Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, is used to improve glycemic control as an adjunct to diet and exercise
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells